Skip to content
OpenCapital
Get started

United Therapeutics UTHR Cash & Equivalents

Cash & Equivalents at other companies

Tenet Healthcare logo
Tenet HealthcareTHC
$2.97B-1.1%
Johnson & Johnson logo
Johnson & JohnsonJNJ
$21.69B-43.6%
Merck & Co. logo
Merck & Co.MRK
$5.4B-38.2%
Insmed logo
InsmedINSM
$582.19M+44.4%
Ethos Technologies, Inc. logo
Ethos Technologies, Inc. LIFE
$10.01M-3.4%
LQD
Liquidia CorporationLQDA
$222.79M+31.2%

Other financials

Income statement

See full
Revenue$781.5M-1.6%
Gross profit$648.1M-7.7%
Operating income$325.8M-14.9%
Net income$274.9M-14.7%
EPS (diluted)$5.82-12.2%

Balance sheet

See full
Total debt$12.2M—
Total equity$5.9B-13.3%
Total assets$6.7B-13.3%

Cash flow

See full
Operating cash flow$463.3M+0.5%
CapEx$100.8M+34.6%
Free cash flow$362.5M-6.2%

Valuation

See full
Market cap$23B+84.1%
P/E17.9×+7.8×
P/S7.3×+3.2×

Profitability

See full
Gross margin86.6%-2.4pp
Operating margin45.3%-1.6pp
Net margin40.6%+0.2pp
FCF margin32.1%-5.6pp

Returns & leverage

See full
Return on equity20.3%+0.3pp
Debt / equity0×—
Current ratio4.8×-0.7×

Where this comes from

Reported directly by United Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue.

The official record: United Therapeutics’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about United Therapeutics's cash & equivalents.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is United Therapeutics's cash & equivalents?
United Therapeutics (UTHR) reported cash & equivalents of $1.28B in Q1 2026.
How has United Therapeutics's cash & equivalents changed year-over-year?
United Therapeutics's cash & equivalents decreased by 32.6% year-over-year, from $1.9B to $1.28B.
What is the long-term trend for United Therapeutics's cash & equivalents?
Over 5 years (2020 to 2025), United Therapeutics's cash & equivalents has grown at a 16.1% compound annual growth rate (CAGR), from $738.7M to $1.56B.
What does cash & equivalents mean?
Cash on hand plus highly liquid investments with maturities of three months or less at purchase — treasury bills, money market funds, and commercial paper.